חזרה לתוצאות החיפוש

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Acute Myeloid Leukemia · Myelodysplastic Syndrome

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Yale-New Haven Hospital, New Haven, Connecticut, United States

    Contact: Study coordinator (Amer Zeidan) · 203-737-7078

  • Northwestern Memorial Hospital, Chicago, Illinois, United States

    Contact: Study coordinator (Jessica Altman) · 312-503-1794

  • Local Institution - 0007, Boston, Massachusetts, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Rupa Narayan) · 617-724-3456

  • Washington University School of Medicine, Siteman Cancer Center, St Louis, Missouri, United States

    Contact: Study coordinator (Geoffrey Uy) · 314-273-1039

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Jamie Koprivnikar) · 551-996-3925

  • Columbia University Irving Medical Center, New York, New York, United States

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Abhishek Maiti) · 832-696-8407

  • Local Institution - 0009, Fairfax, Virginia, United States

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Andre Schuh) · 4168998644

  • Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Sarit Assouline) · 5143408222x28434

  • Local Institution - 0017, Marseille, Bouches-du-Rhône, France

  • Local Institution - 0018, Paris, France

  • Local Institution - 0022, Toulouse, France

  • Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña], Spain

    Contact: Study coordinator (JORDI ESTEVE REYNER) · +34932275400

  • Hospital Universitario Virgen Del Rocio, Seville, Spain

    Contact: Study coordinator (Eduardo Rodriguez) · +34610098690
מובילי המחקר

  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)